John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 1,897 shares at $8.90 ($17K) on 2023-05-02, disclosed to the SEC on 2023-05-03.
Open-market sale of $17k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |